Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-06
1998-08-18
Huff, Sheela
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241471, 4241591, 435339, A61K 39395
Patent
active
057955786
ABSTRACT:
The present invention is directed to a gene encoding an envelope glycoprotein of equine herpesvirus type 1 (EHV-1), the glycoprotein D (gD) gene, its gene product and antibodies directed against gD polypeptides. The envelope glycoproteins of herpesvirus are major targets of the inmune response to herpesviral infection. Hence, an important aspect of this invention is directed towards a vaccine against EHV-1 and treatment of EHV-1 infection by anti-EHV-gD antibodies or antisera.
REFERENCES:
Stokes et al J Gen Virol vol. 70:1173-1183, 1989.
Allen et al J Virology vol. 61 No. 8:2454-2461, 1987.
Whittaker et al J Gen Virol vol. 73: 801-809, 1992.
Huff Sheela
Reeves Julie E.
Research Corporation Technologies Inc.
LandOfFree
Vaccine against equine herpesvirus type 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine against equine herpesvirus type 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine against equine herpesvirus type 1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1112574